Dihydropyridine calcium channel blockers: a rare and reversible cause of hepatotoxicity with cholestasis in a CAPD patient

被引：6
|
作者：
Basile, C [1 ]
Mascia, E
机构：
[1] Hosp Martina Franca, Nephrol Unit, Martina Franca, Italy
[2] Mil Hosp, Dept Surg, Taranto, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1999年 / 14卷 / 11期
关键词：
D O I：
10.1093/ndt/14.11.2776
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：2776 / 2777
页数：2
相关论文
共 50 条
  • [21] Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients
    Staessen, JA
    Birkenhäger, WH
    Fagard, RH
    EUROPEAN HEART JOURNAL, 2000, 21 (01) : 2 - 7
  • [22] Time course for blood pressure lowering of dihydropyridine calcium channel blockers
    Ghamami, Niousha
    Chiang, Sandy Hsiang Yu
    Dormuth, Colin
    Wright, James M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [23] Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers
    Schneeweiss, S
    Soumerai, SB
    Maclure, M
    Dormuth, C
    Walker, AM
    Glynn, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (04) : 388 - 400
  • [24] Calcium channel blockers and hepatotoxicity (vol 95, pg 2145, 2000)
    Lafuente, NG
    Egea, AM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (11): : 3341 - 3341
  • [25] Hepatotoxicity of ethanol: Protective effect of calcium channel blockers in isolated hepatocytes
    Cobreros, A
    Sainz, L
    Lasheras, B
    Cenarruzabeitia, E
    LIVER, 1997, 17 (02): : 76 - 82
  • [26] Dihydropyridine calcium channel blockers may increase mortality in patients with heart failure
    Howlett, JG
    Johnstone, DE
    Cox, JL
    CIRCULATION, 2003, 108 (17) : 341 - 341
  • [27] Angioedema associated with dihydropyridine calcium-channel blockers in a child with Burkitt lymphoma
    Pierce, Wesly A.
    Hederman, April D.
    Gordon, Catherine J.
    Ostrenga, Andrew R.
    Herrington, Betty
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (05) : 402 - 406
  • [28] A cautionary note for nephrologists: Is it time to abandon the use of dihydropyridine calcium channel blockers?
    Jafar, TH
    Pereira, BJG
    SEMINARS IN DIALYSIS, 1999, 12 (03) : 137 - 139
  • [29] Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients
    Kloner, RA
    Vetrovec, GW
    Materson, BJ
    Levenstein, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (02): : 163 - 169
  • [30] Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension
    Hall, WD
    Reed, JW
    Flach, JM
    Yunis, C
    Preisser, J
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (18) : 2029 - 2034
12345